^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG CLASS:

    Macrophage stimulant

    Related drugs:
    Apply
    CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors (NCT04660929)
    Phase 1
    Carisma Therapeutics Inc
    Active, not recruiting
    Last update posted :
    04/11/2024
    Initiation :
    02/02/2021
    Primary completion :
    12/01/2024
    Completion :
    12/01/2024
    HER-2
    |
    HER-2 positive • HER-2 overexpression
    |
    Keytruda (pembrolizumab) • CT-0508
    Tumor Microenvironment in Patients With Localized Osteosarcoma Treated With Mifamurtide: a Translational Study (Micros) (NCT03737435)
    Phase N/A
    Istituto Ortopedico Rizzoli
    Recruiting
    Last update posted :
    03/22/2024
    Initiation :
    12/12/2018
    Primary completion :
    06/30/2024
    Completion :
    06/30/2024
    PD-L1 • CD68
    |
    Mepact (mifamurtide)
    Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT05967416)
    Phase 1
    SIRPant Immunotherapeutics, Inc.
    Recruiting
    Last update posted :
    12/14/2023
    Initiation :
    12/01/2023
    Primary completion :
    03/01/2025
    Completion :
    03/01/2025
    SIRPA
    |
    SIRPant-M (SI-101)